loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Loxapine

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Loxapine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,104Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    French sales sub. of Eisai divests rights of neurology drugs for € 56.5 M
    French sales sub. of Eisai divests rights of neurology drugs for € 56.5 M

    08 Apr 2024

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/24059/french-sales-subsidiary-of-japanese-pharma-firm-eisai-divests-rights-of-neurology-drugs-for-56-5-m.html

    BIOSPECTRUMASIA
    08 Apr 2024
    Share Share
    A 2-pronged attack could improve targeted therapies for colon cancer
    A 2-pronged attack could improve targeted therapies for colon cancer

    17 May 2018

    // Amirah Al Idrus FIERCE BIOTECH

    https://www.fiercebiotech.com/research/a-two-pronged-attack-could-improve-targeted-therapies-for-colon-cancer

    Amirah Al Idrus FIERCE BIOTECH
    17 May 2018
    Share Share
    Alexza literally at end of days as its cash pile set to run out by May
    Alexza literally at end of days as its cash pile set to run out by May

    29 Mar 2016

    // Ben Adams FIERCE BIOTECH

    http://www.fiercebiotech.com/story/alexza-literally-end-days-its-cash-pile-set-run-out-may/2016-03-29

    Ben Adams FIERCE BIOTECH
    29 Mar 2016
    Share Share
    Alexza Pharmaceuticals Receives Positive Nasdaq Listing Determination
    Alexza Pharmaceuticals Receives Positive Nasdaq Listing Determination

    09 Mar 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/alexza-pharmaceuticals-receives-positive-nasdaq-listing-determination-300233504.html

    PR NEWSWIRE
    09 Mar 2016
    Share Share
    Alexza Pharma Reacquires U.S. Commercial Rights for ADASUVE inhalation powder
    Alexza Pharma Reacquires U.S. Commercial Rights for ADASUVE inhalation powder

    24 Feb 2016

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/alexza-pharmaceuticals-reacquires-us-commercial-rights-for-adasuve-loxapine-inhalation-powder-300225004.html

    PR NEWSWIRE
    24 Feb 2016
    Share Share
    FDA updates blood donor deferral policy to reflect most current evidence
    FDA updates blood donor deferral policy to reflect most current evidence

    21 Dec 2015

    // PR NEWS WIRE

    http://www.prnewswire.com/news-releases/alexza-pharmaceuticals-announces-interim-results-from-its-phase-2a-study-of-az-002-staccato-alprazolam-in-epilepsy-patients-300195911.html

    PR NEWS WIRE
    21 Dec 2015
    Share Share